NASDAQ: GWPH       Gw Pharma ADR
Last Price Today's Change   Day's Range   Trading Volume
115.149   -3.671 (3.09%)  113.001 - 118.80  183,077


Avg Volume (4 weeks):426,622
4 Weeks Range:108.00 - 135.84
4 Weeks Price Volatility (%):
52 Weeks Range:92.65 - 143.373
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The Commercial segment distributes and sells the Company's commercial products. The Sativex Research and Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using its cannabinoid technology platform.

  Be the first to like this.


1757  5791  414  600 

Top 10 Active Counters
 NVCN 0.122-0.012 
 FB 171.52-13.57 
 SPY 269.22-4.98 
 TVIX 8.55+1.67 
 MU 59.60-0.98 
 QQQ 166.05-4.97 
 EEM 48.51-0.70 
 UVXY 17.05+2.69 
 VXX 44.70+5.20 
 AMD 11.39-0.08 
Partners & Brokers